Intense Dose-Dense Sequential Chemotherapy With Epirubicin, Paclitaxel, and Cyclophosphamide Compared With Conventionally Scheduled Chemotherapy in High-Risk Primary Breast Cancer: Mature Results of an AGO Phase III Study

Erstveröffentlichung
2010Authors
Moebus, Volker
Jackisch, Christian
Lueck, Hans-Joachim
du Bois, Andreas
Thomssen, Christoph
Wissenschaftlicher Artikel
Published in
Journal of clinical oncology ; 28 (2010), 17. - S. 2874-2880. - ISSN 0732-183X. - eISSN 1527-7755
Link to publication
https://dx.doi.org/10.1200/JCO.2009.24.7643Institutions
UKU. Klinik für Frauenheilkunde und GeburtshilfeSubject headings
[Free subject headings]: ADJUVANT CHEMOTHERAPY | RANDOMIZED-TRIAL | FOLLOW-UP | DOCETAXEL | FLUOROURACIL | METHOTREXATE | LEUKEMIA | OUTCOMES | THERAPY | WOMEN[DDC subject group]: DDC 610 / Medicine & health